Johannes A Romijn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Johannes A Romijn has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Johannes Wa Smit
Department of General Internal Medicine 463, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands
5 shared publications L.M. Havekes
4 shared publicationsP.C.N. Rensen
4 shared publications- Hanno Pijl
Leiden University Medical Center
3 shared publications Y. Wang
3 shared publications- Ep Corssmit
Afd. Endocrinologie en Metabolisme, Academisch Medisch Centrum/Universiteit van Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam
2 shared publications
Latest Publications
- 1 September 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36, S54
SUN-P004: Variability and Reproducibility of the Postprandial Response
- 1 September 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36, S54
SUN-P004: Variability and Reproducibility of the Postprandial Response
- Open Access
- 19 December 2011
- Published by Springer Nature in BMC Nephrology
- Vol. 12 (1) , 69
Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition
On dialysis, survival among patients with diabetes mellitus is inferior to survival of non-diabetic patients. We hypothesized that patients with diabetes as primary renal disease have worse survival compared to patients with diabetes as a co-morbid condition and aimed to compare all-cause mortality between these patient groups.
- 19 December 2011
- Published by Springer Nature in BMC Nephrology
- Vol. 12 (1) , 69
Open AccessSurvival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition
On dialysis, survival among patients with diabetes mellitus is inferior to survival of non-diabetic patients. We hypothesized that patients with diabetes as primary renal disease have worse survival compared to patients with diabetes as a co-morbid condition and aimed to compare all-cause mortality between these patient groups.
- 30 June 2011
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 12 (1) , 2
5 THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENDIN-4 INHIBITS VLDL BIOSYNTHESIS AND SECRETION IN APOE*3-LEIDEN MICE
- 30 June 2011
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 12 (1) , 2
5 THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENDIN-4 INHIBITS VLDL BIOSYNTHESIS AND SECRETION IN APOE*3-LEIDEN MICE
- 30 June 2011
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 12 (1) , 38
172 NIACIN, ATORVASTATIN AND FENOFIBRATE DECREASE PLASMA CETP BY REDUCTION OF THE HEPATIC MACROPHAGE CONTENT IN APOE*3-LEIDEN.CETP MICE
- 30 June 2011
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 12 (1) , 38
172 NIACIN, ATORVASTATIN AND FENOFIBRATE DECREASE PLASMA CETP BY REDUCTION OF THE HEPATIC MACROPHAGE CONTENT IN APOE*3-LEIDEN.CETP MICE
- 30 June 2010
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 11 (2) , 71
P260 CETP EXPRESSION REVERSES THE RECONSTITUTED HDL-INDUCED INCREASE IN VLDL
- 30 June 2010
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 11 (2) , 71
P260 CETP EXPRESSION REVERSES THE RECONSTITUTED HDL-INDUCED INCREASE IN VLDL
- 30 June 2010
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 11 (1) , 69-70
Hepatocyte-specific Inflammation Directly Enhances VLDL-triglyceride Production in Mice
- 30 June 2010
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 11 (1) , 69-70
Hepatocyte-specific Inflammation Directly Enhances VLDL-triglyceride Production in Mice
- Open Access
- 11 June 2010
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11 (1) , 92
Low penetrance of a SDHB mutation in a large Dutch paraganglioma family
Germline mutations of the succinate dehydrogenase subunit B gene (SDHB) predispose carriers for paragangliomas, and current estimates of the chance of mutation carriers actually developing tumors (penetrance) are high. We evaluate the phenotype and penetrance of a germline SDHB mutation in a large and clinically well-characterized paraganglioma family.
- 11 June 2010
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11 (1) , 92
Open AccessLow penetrance of a SDHB mutation in a large Dutch paraganglioma family
Germline mutations of the succinate dehydrogenase subunit B gene (SDHB) predispose carriers for paragangliomas, and current estimates of the chance of mutation carriers actually developing tumors (penetrance) are high. We evaluate the phenotype and penetrance of a germline SDHB mutation in a large and clinically well-characterized paraganglioma family.
- Open Access
- 27 March 2010
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 7 (1) , 24
High levels of dietary stearate promote adiposity and deteriorate hepatic insulin sensitivity
Background: Relatively little is known about the role of specific saturated fatty acids in the development of high fat diet induced obesity and insulin resistance. Here, we have studied the effect of stearate in high fat diets (45% energy as fat) on whole body energy metabolism and tissue specific insulin sensitivity. Methods: C57Bl/6 mice were fed a low stearate diet based on palm oil or one of two stearate rich diets, one diet based on lard and one diet based on palm oil supplemented with tristearin (to the stearate level of the lard based diet), for a period of 5 weeks. Ad libitum fed Oxidative metabolism was assessed by indirect calorimetry at week 5. Changes in body mass and composition was assessed by DEXA scan analysis. Tissue specific insulin sensitivity was assessed by hyperinsulinemic-euglycemic clamp analysis and Western blot at the end of week 5. Results: Indirect calorimetry analysis revealed that high levels of dietary stearate resulted in lower caloric energy expenditure characterized by lower oxidation of fatty acids. In agreement with this metabolic phenotype, mice on the stearate rich diets gained more adipose tissue mass. Whole body and tissue specific insulin sensitivity was assessed by hyperinsulinemic-euglycemic clamp and analysis of insulin induced PKBser473 phosphorylation. Whole body insulin sensitivity was decreased by all high fat diets. However, while insulin-stimulated glucose uptake by peripheral tissues was impaired by all high fat diets, hepatic insulin sensitivity was affected only by the stearate rich diets. This tissue-specific pattern of reduced insulin sensitivity was confirmed by similar impairment in insulin-induced phosphorylation of PKBser473 in both liver and skeletal muscle. Conclusion: In C57Bl/6 mice, 5 weeks of a high fat diet rich in stearate induces a metabolic state favoring low oxidative metabolism, increased adiposity and whole body insulin resistance characterized by severe hepatic insulin resistance. These results indicate that dietary fatty acid composition per sé rather than dietary fat content determines insulin sensitivity in liver of high fat fed C57Bl/6 mice.
- 27 March 2010
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 7 (1) , 24
Open AccessHigh levels of dietary stearate promote adiposity and deteriorate hepatic insulin sensitivity
Background: Relatively little is known about the role of specific saturated fatty acids in the development of high fat diet induced obesity and insulin resistance. Here, we have studied the effect of stearate in high fat diets (45% energy as fat) on whole body energy metabolism and tissue specific insulin sensitivity. Methods: C57Bl/6 mice were fed a low stearate diet based on palm oil or one of two stearate rich diets, one diet based on lard and one diet based on palm oil supplemented with tristearin (to the stearate level of the lard based diet), for a period of 5 weeks. Ad libitum fed Oxidative metabolism was assessed by indirect calorimetry at week 5. Changes in body mass and composition was assessed by DEXA scan analysis. Tissue specific insulin sensitivity was assessed by hyperinsulinemic-euglycemic clamp analysis and Western blot at the end of week 5. Results: Indirect calorimetry analysis revealed that high levels of dietary stearate resulted in lower caloric energy expenditure characterized by lower oxidation of fatty acids. In agreement with this metabolic phenotype, mice on the stearate rich diets gained more adipose tissue mass. Whole body and tissue specific insulin sensitivity was assessed by hyperinsulinemic-euglycemic clamp and analysis of insulin induced PKBser473 phosphorylation. Whole body insulin sensitivity was decreased by all high fat diets. However, while insulin-stimulated glucose uptake by peripheral tissues was impaired by all high fat diets, hepatic insulin sensitivity was affected only by the stearate rich diets. This tissue-specific pattern of reduced insulin sensitivity was confirmed by similar impairment in insulin-induced phosphorylation of PKBser473 in both liver and skeletal muscle. Conclusion: In C57Bl/6 mice, 5 weeks of a high fat diet rich in stearate induces a metabolic state favoring low oxidative metabolism, increased adiposity and whole body insulin resistance characterized by severe hepatic insulin resistance. These results indicate that dietary fatty acid composition per sé rather than dietary fat content determines insulin sensitivity in liver of high fat fed C57Bl/6 mice.
- Open Access
- 14 April 2009
- Published by Wiley in The Journal of Physiology
- Vol. 587 (8) , 1637
The muscle-liver axis: does aerobic fitness induce intrahepatic protection against non-alcoholic fatty liver disease?
- 14 April 2009
- Published by Wiley in The Journal of Physiology
- Vol. 587 (8) , 1637
Open AccessThe muscle-liver axis: does aerobic fitness induce intrahepatic protection against non-alcoholic fatty liver disease?
- 22 November 2008
- Vol. 152 (47) , 2565-70
[Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center].
To evaluate the long-term outcome of transsphenoidal resection of pituitary adenomas at the Leiden University Medical Center (LUMC), The Netherlands. Retrospective, descriptive. 416 consecutive patients undergoing surgery for pituitary adenoma at the LUMC between 1978 and 2004 were included; 174 patients with non-functioning macroadenomas (NFMA), 164 patients with acromegaly and 78 patients with Cushing's disease. Biochemical remission was achieved in 66% of patients with acromegaly, and 72% of patients with Cushing's disease; incidence of pituitary failure was low in these patients (5% and 18% respectively). In 82% of the patients with NFMA visual function improved whereas the percentage with any degree of pituitary failure increased from 85% (preoperatively) to 95% (postoperatively). During follow-up of 10-15 years, the recurrence rate for acromegaly and Cushing's disease was 9% and for NFMA it was 15%. Transsphenoidal resection is an effective treatment in most, but not all, patients with pituitary adenomas. The surgical results at the LUMC are comparable with those obtained in important international centres. All patients cured by surgery need lifelong follow-up, because of the real risk of recurrent disease.
- 22 November 2008
- Vol. 152 (47) , 2565-70
[Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center].
To evaluate the long-term outcome of transsphenoidal resection of pituitary adenomas at the Leiden University Medical Center (LUMC), The Netherlands. Retrospective, descriptive. 416 consecutive patients undergoing surgery for pituitary adenoma at the LUMC between 1978 and 2004 were included; 174 patients with non-functioning macroadenomas (NFMA), 164 patients with acromegaly and 78 patients with Cushing's disease. Biochemical remission was achieved in 66% of patients with acromegaly, and 72% of patients with Cushing's disease; incidence of pituitary failure was low in these patients (5% and 18% respectively). In 82% of the patients with NFMA visual function improved whereas the percentage with any degree of pituitary failure increased from 85% (preoperatively) to 95% (postoperatively). During follow-up of 10-15 years, the recurrence rate for acromegaly and Cushing's disease was 9% and for NFMA it was 15%. Transsphenoidal resection is an effective treatment in most, but not all, patients with pituitary adenomas. The surgical results at the LUMC are comparable with those obtained in important international centres. All patients cured by surgery need lifelong follow-up, because of the real risk of recurrent disease.